KAMRAN QURESHI: Open Payments
NPI 1417119926 · LAKE ST LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$101,639 in 73 payments from 5 companies in 2025. Trend: 2023 $25,840 · 2024 $101,084 · 2025 $101,639
Speaker / faculty: $91,583Travel & lodging: $7,646Food & beverage: $2,379Education: $32
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 40 | $57,225 |
| Gilead Sciences, Inc. | 20 | $31,947 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $12,210 |
| Novo Nordisk Inc | 2 | $136 |
| Mirum Pharmaceuticals, Inc. | 1 | $121 |
Products named: REZDIFFRA, Livdelzi, XIFAXAN, Epclusa, Livmarli.
Industry payments across MO — which companies pay providers there.
